This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: H. Lundbeck A/s. Active years: 2009-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Koge, DK (2009 - 2010)
- Køge, DK (2010)
Company Filing History:
Years Active: 2009-2010
Title: Helle Eliasen - Pioneering Sustainable Innovation in Pharmaceuticals
Introduction:
Helle Eliasen, a distinguished inventor hailing from Koge, DK, is making waves in the world of pharmaceutical innovation. With a deep-rooted passion for sustainability, Eliasen's dedication towards creating a greener future through his inventive solutions has set him apart in the realm of inventors and innovators.
Latest Patents:
Eliasen has proven his prowess in the field with a total of 3 patents under his belt, with his most recent breakthrough being the development of the Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base. This invention focuses on enhancing the effectiveness and accessibility of the well-known antidepressant drug escitalopram through innovative formulations and processes, introducing a new method for producing purified salts and formulations of escitalopram for improved patient outcomes.
Career Highlights:
Currently employed at H. Lundbeck A/S, Eliasen's contributions to the pharmaceutical industry have been instrumental in propelling the company towards sustainable practices and cutting-edge pharmaceutical solutions. His innovative mindset and commitment to excellence have paved the way for groundbreaking advancements in drug development and formulation.
Collaborations:
Throughout his career, Eliasen has collaborated with esteemed professionals in the field, including Robert Dancer and Hans Petersen. These collaborations have enriched his work, fostering a culture of innovation and knowledge exchange that drives progress within the pharmaceutical industry.
Conclusion:
In conclusion, Helle Eliasen's relentless pursuit of innovation and sustainability in the pharmaceutical sector has positioned him as a standout figure among inventors and innovators. His inventive spirit, combined with a dedication to creating transformative solutions, is driving positive change and shaping a more sustainable future for the pharmaceutical industry and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile